"Cancer Treatment Centers of America is a multi-facility, rapidly growing healthcare organization and the successful execution of such a complex, big-bang activation is a testament to its remarkable organizational discipline," said R. Andrew Eckert, Eclipsys president and chief executive officer. "CTCA understands the value of integrating clinical and financial operations to help achieve maximum outcome improvements."

With the additional activation of the Eclipsys Sunrise Pharmacy product, CTCA now has an integrated medication ordering and delivery system.

The new technology allows the hospitals to better administer chemotherapy treatment, according to CTCA officials. Maximum allowable dose capabilities, order signature policies, and order sequencing will help make sure patients receive the right dose of medication at the right time, they say. The system also helps CTCA manage approved and experimental medications used for the treatment of all types of cancer.

"Eclipsys' solutions are playing a critical role in helping improve our care delivery as we seek to standardize our evidence-based and best practice care processes at each of our locations," said Edgar D. Staren, MD, chief medical officer at CTCA.

CTCA also activated Eclipsys registration and financial management software, to extend the power of the EMR to gather patient data as soon as an individual enters the healthcare system and to improve claims delivery. CTCA is also using Sunrise Enterprise Scheduling to manage resources, and create and schedule appointments across all of its care settings.